SC comes down heavily on Allopathic doctors prescribing expensive medicines; says "IMA needs to put its house in order"

HORNBILLTV
April 23,2024 06:51 PM
HORNBILL TV

Highlights

The Supreme Court has taken strong exceptions to the Indian Medical Association for alleged unethical acts such as prescribing medicines which are "expensive and unnecessary".

New Delhi [India], April 23 (HBTV): The Supreme Court on Tuesday took strong exceptions to the Indian Medical Association (IMA) for alleged unethical acts such as prescribing medicines which are "expensive and unnecessary," saying the association needs to "put its house in order." 



"The petitioner (IMA) needs to put its own house in order regarding alleged unethical acts of the organization where medicines are prescribed, which is expensive and unnecessary," said a bench of Justices Hima Kohli and Ahsanuddin Amanullah.  



The apex court said that wherever there is a misuse of the position by the IMA to prescribe expensive medicines and the line of treatment, it needs "closer examination."   



It further told IMA that while it is pointing fingers at Patanjali, four fingers are pointing back at them. 



"Your (IMA) doctors also endorsing medicines in the allopathic field. If that's happening, why should we not turn the beam at you (IMA)?" the bench asked.  



"Your (IMA) members also endorsed such products... your members are prescribing medicines," the bench said. 



The bench was hearing a case filed by IMA against an alleged smear campaign carried out by Patanjali Ayurveda Ltd and its founders against the COVID-19 vaccination drive and modern medicine.     



The apex court said it would explore the larger issue of misleading health claims made by Fast-Moving Consumer Goods (FMCG) companies and ‘impleaded’ the Ministry of Consumer Affairs and the Ministry of Information and Broadcasting as parties to the case. 



The top court said FMCG companies were taking the public for a ride by publishing advertisements of products that affect the health of babies, school-going children, and senior citizens. It asked the Centre about the steps taken by it regarding misleading advertisements over the past three years.     



"We are not looking at the respondents (Patanjali) alone. The kind of coverage we have seen, now we are looking at all. We are looking at children, babies, women, and no one can be taken for a ride and the Union (government) must wake up to this," the bench said.  



The apex court has asked the licensing authorities of all states and Union Territories to be impleaded as parties in the case. It further directed the addition of the Indian Medical Association as a party to the case.



The bench said it is not here to "gun for a particular party," but in the larger interest of consumers and the public to know how they are being misled; their entitlement to know the truth; and what steps they can take.  



During the contempt case hearing for misleading advertisement by Patanjali Ayurved, the bench was informed that an apology was published in 67 newspapers.   



The bench asked senior advocate Mukul Rohatgi, representing Patanjali, if the public apology published by them in newspapers yesterday were as big as their advertisements. Rohatgi said that the advertisements cost INR 10 lakh.   



Co-founder of Patanjali Ayurved Ltd., Baba Ramdev and Acharya Balkrishna, Patanjali's Managing Director, were present before the bench pursuant to earlier directives.   



Adjourning the hearing till April 30, the bench asked Patanjali's lawyers to bring on record the copy of the apology advertisements.  



"Do not enlarge them and supply it to us. We want to see the actual size. We want to see that when you issue an Ad, it does not mean we have to see it by a microscope. It is not meant to be on paper but also read," the bench said.     



On April 16, Ramdev and Balkrishna apologized to the Supreme Court for publishing misleading advertisements and making comments against allopathic medicines and Ramdev assured that he would "remain conscious about it in the future."   



(ANI) This is a syndicated news feed. HBTV has edited it for clarity.